Wednesday, 24 May 2017

Australia News

  • Nohla Therapeutics raises $21mn

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Nohla Therapeutics, a developer of cellular therapies for haematological disorders and immunological diseases, has raised over $21 million from several institutional investors. ...Read more

  • Australia's TransBio, DendroCyte to develop antibody for transplant rejection

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australia based TransBio and DendroCyte BioTech have entered into a multi-year collaboration to discover and develop novel antibody therapeutics directed against CD83, a relative...Read more

  • New technologies push growth of Cochlear

    Australia |  Analysis | By BioSpectrum Bureau | 0 Comment

    Innovation, passion and expertise have brought recognition to Cochlear for its niche focus on hearing aids medical devices. By now, around 250,000 people in over 100 countries are living be...Read more

  • Australian body launches research translation initiative

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australia's body for supporting health and medical research National Health and Medical Research Council (NHMRC) has launched Research Translation Faculty for health and medical ...Read more

  • CSL marks a billion dollar in profits

    Australia |  Analysis | By Amrita Tejasvi | 0 Comment

    One of Asia Pacific's biggest names in the pharmaceutical industry, CSL, retained its second position in BioSpectrum Asia's Top 20 list. The pharmaceutical giant recorded net profit of $1...Read more

  • Pharmaxis, NovaQuest enter $40 mn agreement

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Pharmaceutical company Pharmaxis announced the signing of a financing agreement with NovaQuest Pharma Opportunities Fund III, under which NovaQuest will invest up to $40 million...Read more

  • Innate Immunotherapeutics completes $9mn IPO

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Innate Immunotherapeutics has raised $8.9 million (AUD10 million) through its Initial Public Offer (IPO) that the company would channelize to commence planning its clinical trial...Read more

  • BioDiem gets hepatitis vaccine tech from Canberra univ

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australian infectious disease therapy and vaccine development company BioDiem has signed an agreement to license a novel vaccine technology from the University of Canberra, expan...Read more

  • Infect mosquitoes with Wolbachia, stop diseases

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected with the bacteria Wolbachia lose their ability to spread diseases such ...Read more

  • NZ gets drug that glows brain tumour

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: A novel drug, GLIOLAN (aminolevulinic acid HCl), that helps neurosurgeons to better visualise and remove malignant brain tumours has been approved for marketing and distribution ...Read more

  • Australia's Alchemia announces sale of Fondaparinux IP

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Alchemia, an Australian drug discovery and development company, has announced that it has entered into a binding term sheet for the sale of the worldwide exclusive intellectual p...Read more

  • UBI quarterly service fees increase by 311%

    Australia |  Company results | By BioSpectrum Bureau | 0 Comment

    Singapore: Medical diagnostics company Universal Biosensors (UBI) published its quarterly cash flow report for the quarter ending December 31, 2012. The report highlighted strong revenue g...Read more

  • Mayne pharma to expand its Greenville facility; add 110 jobs

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australia-based specialty pharmaceutical company, Mayne pharma, recently announced plans to invest $65 million at its facility in Greenville and add 110 jobs in the next five yea...Read more

  • LBT Innovations inks partnership with French tech firm

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australian medical technology company, LBT Innovations, has signed a license agreement with French in vitro diagnostics company, bioMérieux, for LBT's foundational culture pla...Read more

  • Garvan Institute develops first-ever biologically stable antibodies

    Australia |  News | By Vipul Murarka | 0 Comment

    Singapore: One of the most challenging tasks ahead of pharmaceutical companies is to create antibodies that are stable enough to meet stringent requirements necessary for production in larg...Read more

  • Future of Healthcare in Asia

    Australia |  Analysis | By Amrita Tejasvi | 0 Comment

    Healthcare industry is in a period of evolution accelerated by changing demographics and market forces propelled by insurge of healthcare awareness, availability of technology and fast acce...Read more

  • Phylogica appoints CEO, CSO, CFO

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Leading Australian peptide drug discovery company Phylogica appointed Dr Richard Hopkins as the company's new CEO as part of a broad company strategic review. He will be appointe...Read more

  • New South Wales govt launches Medical Devices Fund

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The New South Wales (NSW) Government in Australia has established a Medical Devices Fund under which it will aid development and commercialization of innovative medical devices i...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls